Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP857796.RA_48VSonq9fub-Bb1zRbUz-edFqrux6yPxL5_M3E2FGQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP857796.RA_48VSonq9fub-Bb1zRbUz-edFqrux6yPxL5_M3E2FGQ130_assertion type Assertion NP857796.RA_48VSonq9fub-Bb1zRbUz-edFqrux6yPxL5_M3E2FGQ130_head.
- NP857796.RA_48VSonq9fub-Bb1zRbUz-edFqrux6yPxL5_M3E2FGQ130_assertion description "[These observations suggest that the NAT1*11 variant and the GSTM1 wild-type genotype contribute to a more favorable outcome in patients treated for neuroblastoma and are the first to demonstrate a relationship between NAT1 and GSTM1 genotypes in childhood neuroblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857796.RA_48VSonq9fub-Bb1zRbUz-edFqrux6yPxL5_M3E2FGQ130_provenance.
- NP857796.RA_48VSonq9fub-Bb1zRbUz-edFqrux6yPxL5_M3E2FGQ130_assertion evidence source_evidence_literature NP857796.RA_48VSonq9fub-Bb1zRbUz-edFqrux6yPxL5_M3E2FGQ130_provenance.
- NP857796.RA_48VSonq9fub-Bb1zRbUz-edFqrux6yPxL5_M3E2FGQ130_assertion SIO_000772 17700360 NP857796.RA_48VSonq9fub-Bb1zRbUz-edFqrux6yPxL5_M3E2FGQ130_provenance.
- NP857796.RA_48VSonq9fub-Bb1zRbUz-edFqrux6yPxL5_M3E2FGQ130_assertion wasDerivedFrom befree-20150227 NP857796.RA_48VSonq9fub-Bb1zRbUz-edFqrux6yPxL5_M3E2FGQ130_provenance.
- NP857796.RA_48VSonq9fub-Bb1zRbUz-edFqrux6yPxL5_M3E2FGQ130_assertion wasGeneratedBy ECO_0000203 NP857796.RA_48VSonq9fub-Bb1zRbUz-edFqrux6yPxL5_M3E2FGQ130_provenance.